The highest study rate per million residents was achieved in Argentina, according to Flavio Arce, Regional External Partnership Medical Lead, Latam Pfizer.

We performed more procedures in 2021 than we did in the previous 10 years combined. We were able to complete 210 clinical investigations as opposed to 118 in 2017: an increase of 70%.

According to the national pharmaceutical industry's referents, these circumstances demonstrate Argentina's potential to develop into a regional center or hub for clinical research.